State UT
Clinical Trials in Utah
Recruiting clinical trials with at least one study location in Utah. Data updated daily from ClinicalTrials.gov.
Top Conditions in Utah
NCT04110522 N/A
Recruiting
Psoriatic Arthritis D2P Screening
Condition
Psoriatic Arthritis
Enrollment
18,000 pts
Location
United States
Sponsor
Jessica Walsh
NCT05736653 N/A
Recruiting
PCMS Task After Moderate-to-severe Stroke
Condition
Stroke
Enrollment
40 pts
Location
United States
Sponsor
University of Utah
NCT06651177 Phase 2
Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Op...
Condition
Opioid Use Disorder
Enrollment
310 pts
Location
United States
Sponsor
T. John Winhusen, PhD
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT07060716 N/A
Recruiting
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monit...
Condition
Kidney Transplant Rejection
Enrollment
125 pts
Location
United States, Germany
Sponsor
Insight Molecular Diagnostics
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06654895 N/A
Recruiting
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
Condition
Sepsis, Septic Shock
Enrollment
700 pts
Location
United States
Sponsor
Bluejay Diagnostics, Inc.
NCT02328677 N/A
Recruiting
ColoCare Study - Colorectal Cancer Cohort
Condition
Colorectal Cancer
Enrollment
5,000 pts
Location
United States, Germany
Sponsor
University of Utah
NCT03988439 Phase 4
Recruiting
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants ...
Condition
Psoriasis
Enrollment
45 pts
Location
United States, Dominican Republic, Panama
Sponsor
Bausch Health Americas, Inc.
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
NCT06068075 N/A
Recruiting
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Dia...
Condition
Ewing Sarcoma
Enrollment
340 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT04996875 Phase 2
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Condition
Advanced Systemic Mastocytosis (AdvSM)
Enrollment
140 pts
Location
United States, Australia, Austria
Sponsor
Cogent Biosciences, Inc.
NCT07470853 Phase 1
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With A...
Condition
PROC
Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06810544 Phase 1, Phase 2
Recruiting
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in P...
Condition
Non Small Cell Lung Cancer
Enrollment
191 pts
Location
United States
Sponsor
Tango Therapeutics, Inc.
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or...
Condition
Non-Small Cell Lung Cancer
Enrollment
251 pts
Location
United States, France, Germany
Sponsor
Pierre Fabre Medicament
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
NCT03567889 Phase 3
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/...
Condition
Melanoma Stage IIIB
Enrollment
186 pts
Location
United States, Spain, Switzerland
Sponsor
Philogen S.p.A.
NCT06070350 Phase 3
Recruiting
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage...
Condition
Hemorrhagic Shock
Enrollment
1,000 pts
Location
United States
Sponsor
Philip Spinella
NCT05591118 Phase 3
Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Condition
Pulmonary Embolism
Enrollment
500 pts
Location
United States
Sponsor
NYU Langone Health
NCT06381674 N/A
Recruiting
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based P...
Condition
Mild Traumatic Brain Injury, Concussion
Enrollment
100 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc